NAD+ 1000mg

NAD+ accepts electrons during catabolic reactions in glycolysis and the TCA cycle, becoming reduced to NADH, which then donates electrons to Complex I of the mitochondrial electron transport chain to drive ATP synthesis via oxidative phosphorylation. The NAD+/NADH ratio reflects cellular redox state and regulates metabolic flux — a high ratio favors oxidative metabolism and sirtuin activity, while a low ratio signals reductive stress and can impair mitochondrial function. Researchers measure this ratio using enzymatic cycling assays or fluorescence-based NAD+/NADH sensors to assess metabolic status in various experimental conditions.

Mammals express seven sirtuin isoforms (SIRT1–7), each localized to different subcellular compartments: SIRT1, SIRT6, and SIRT7 are nuclear; SIRT3, SIRT4, and SIRT5 are mitochondrial; SIRT2 is primarily cytoplasmic. All require NAD+ as a co-substrate to catalyze protein deacylation (removing acetyl or other acyl groups from lysine residues), coupling the reaction to nicotinamide and O-acetyl-ADP-ribose generation. Because sirtuins are obligate NAD+ consumers, their activity is directly regulated by intracellular NAD+ availability, linking cellular metabolic status to epigenetic regulation, stress response, and mitochondrial biogenesis.

Dissolve NAD+ in ultrapure sterile water or appropriate aqueous buffer (such as PBS or Tris-HCl, pH 7.0–8.0) to the desired concentration. NAD+ is freely water-soluble. Prepare stock solutions at concentrations of 10–100 mM depending on the assay requirements. Aliquot reconstituted solutions into single-use volumes to minimize freeze-thaw degradation, and store aliquots at -20°C or -80°C protected from light. NAD+ is hygroscopic and susceptible to hydrolysis at extreme pH values; solutions should be prepared fresh when possible or used within one month of reconstitution for enzymatic assays requiring precise NAD+ quantification.

PARPs (poly(ADP-ribose) polymerases), particularly PARP-1 and PARP-2, are activated by DNA strand breaks and consume NAD+ to synthesize branched poly(ADP-ribose) chains on target proteins at damage sites, recruiting DNA repair machinery and chromatin remodelers. In research, exogenous NAD+ is a required substrate for in-vitro PARP activity assays, where radiolabeled or biotinylated NAD+ is used to quantify PARP catalytic output. The competition between PARPs and sirtuins for the cellular NAD+ pool is a major area of investigation in aging research, as hyperactivation of PARP-1 by accumulated DNA damage can deplete NAD+ below the threshold required for sirtuin-mediated metabolic regulation.

Published research in rodent and human tissue samples has documented age-dependent NAD+ decline across multiple organs including liver, skeletal muscle, brain, and adipose tissue. The proposed mechanisms include: increased NAD+ consumption by CD38 (whose expression rises with inflammation and aging), chronic PARP activation from accumulated DNA damage, decreased expression of NAMPT (the rate-limiting enzyme in the NAD+ salvage pathway), and altered flux through de novo biosynthesis from tryptophan. In preclinical studies, supplementation with NAD+ precursors (NMN and NR) restored tissue NAD+ levels and reversed age-associated metabolic dysfunction, supporting the hypothesis that NAD+ decline is a causal contributor to aging phenotypes rather than merely a correlate.